肺动脉高压AI风险分层诊断准确性比较系统综述数据表
包含14095例肺动脉高压患者的AI与常规风险分层诊断准确性比较数据表。

基本信息
资源简介
肺动脉高压AI风险分层诊断准确性比较系统综述数据表
【一句话概览】
本数据集是 figshare 公开的结构化表格数据集,收录 1 个文件、合计 398.47 KB,主题涵盖 AI—artificial intelligence、deep learning、diagnostic accuracy、AI prediction、risk strategies,可用于统计建模、特征工程与队列分析,CC BY 4.0 许可开放获取。
【数据集背景】
本数据集源站标题为《Data Sheet 1_Comparative diagnostic accuracy of artificial intelligence-derived risk stratification versus conventional risk stratification methods in pulmonary hypertension patients: a systematic review and meta-analysis.docx》。配套论文《Diagnostic test accuracy of artificial intelligence analysis of cross-sectional imaging in pulmonary hypertension: a systematic literature review》发表于 The British Journal of Radiology(2021),DOI:10.1259/bjr.20210332。源站首次发布:2025-11-19。
【数据内容】
源站原始描述:BackgroundAccurate risk stratification in pulmonary hypertension (PH) is integral for optimizing therapeutic strategies and improving patient outcomes. Recent artificial intelligence (AI) models have demonstrated notable efficacy in risk stratification of PH, achieving area under the curve (AUC) values of 0.94 and 0.81 in internal and external validation cohorts, respectively. This meta-analysis aims to demonstrate the effectiveness of AI models in the risk stratification of PH by comparing thei…
【数据结构与技术规格】
文件数 1 个,合计 398.47 KB。Data Sheet 1_Comparative diagnostic accuracy of artificial intelligence-derived risk stratification versus conventional risk stratification methods in.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,398.47 KB。数据集 DOI:10.3389/frai.2025.1692829.s001。
【主题与分类】
源站学科分类:Knowledge Representation and Machine Learning。主题标签:AI—artificial intelligence、deep learning、diagnostic accuracy、AI prediction、risk strategies、pulmonary hypertension。
【适用方向】
结构化表格数据可直接用于统计建模、特征工程与队列分析。
【获取与许可】
源站页面:https://frontiersin.figshare.com/articles/dataset/Data_Sheet_1_Comparative_diagnostic_accuracy_of_artificial_intelligence-derived_risk_stratification_versus_conventional_risk_stratification_methods_in_pulmonary_hypertension_patients_a_systematic_review_and_meta-analysis_docx/30656270
使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。
规范引用:Ahmed, Faizan; Haider, Faseeh; Arham, Muhammad; Dad, Allah; Bakht, Kinza; Hashim, Muhammad Moseeb Ali; et al. (2025). Data Sheet 1_Comparative diagnostic accuracy of artificial intelligence-derived risk stratification versus conventional risk stratification methods in pulmonary hypertension patients…
下载信息
注册下载
需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。
暂未开放公开下载
无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。
免登录有偿下载
公开数据集受托下载与技术交付服务。
提供高速下载与技术交付服务(收技术服务费,非数据销售)
暂未开放当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。
使用方式
数据集获取(Figshare)
- 源站标题:Data Sheet 1_Comparative diagnostic accuracy of artificial intelligence-derived risk stratification versus conventional risk stratification methods in pulmonary hypertension patients: a systematic review and meta-analysis.docx
- DOI:10.3389/frai.2025.1692829.s001
- 发布日期:2025-11-19
- 文件数:1 个
- 文件总体积:398.47 KB
- 源站页面:https://frontiersin.figshare.com/articles/dataset/Data_Sheet_1_Comparative_diagnostic_accuracy_of_artificial_intelligence-derived_risk_stratification_versus_conventional_risk_stratification_methods_in_pulmonary_hypertension_patients_a_systematic_review_and_meta-analysis_docx/30656270
命令行下载
curl -L -o "Data Sheet 1_Comparative diagnostic accuracy of artificial intelligence-derived risk stratification versus conventional risk stratification methods in.docx" "https://ndownloader.figshare.com/files/59691947"
文件清单
Data Sheet 1_Comparative diagnostic accuracy of artificial intelligence-derived risk stratification versus conventional risk stratification methods in.docx(398.47 KB)
文件总体积 398.47 KB(源站 API 实测)。
数据说明
BackgroundAccurate risk stratification in pulmonary hypertension (PH) is integral for optimizing therapeutic strategies and improving patient outcomes. Recent artificial intelligence (AI) models have demonstrated notable efficacy in risk stratification of PH, achieving area under the curve (AUC) values of 0.94 and 0.81 in internal and external validation cohorts, respectively. This meta-analysis aims to demonstrate the effectiveness of AI models in the risk stratification of PH by comparing their performance to conventional risk stratification methods.
MethodsA systematic search of five databases (PubMed, Embase, ScienceDirect, Scopus, and the Cochrane Library) was conducted from inception to March 2025. Statistical analysis was performed in R (version 2024.12.1 + 563) using 2 × 2 contingency data. Sensitivity, specificity, and diagnostic odds ratio (DOR) were pooled using a bivariate random-effects model (reitsma from the mada package), while the AUC was meta-analyzed using logit-transformed values via the metagen() function from the meta package.
ResultsSix studies were included in the final synthesis, comprising 14,095 patients: 4,481 in internal test datasets and 4,948 in external datasets. AI risk stratification models showed significant performance with a logit mean difference of 0.26 (95% CI 0.09–0.43; p = 0.31), having low heterogeneity (I2 = 14.3%) as compared to conventional methods. Furthermore, pooled sensitivity and specificity were 0.77 (95% CI 0.74–0.79) and 0.72 (95% CI 0.70–0.75) in favor of AI methods, respectively. The heterogeneities for pooled sensitivity and specificity were 57.1% (p = 0.04) and 91.8% (p Artificial intelligence-based risk stratification demonstrates significantly higher diagnostic performance compared to conventional methods in pulmonary hypertension. The higher pooled AUC, sensitivity, specificity, and DOR highlight AI’s potential to enhance predictive accuracy, guiding better treatment strategies. Nonetheless, more superior quality studies are needed to validate AI models for clinical integration.
许可
CC BY 4.0
引用
学术使用请引用 DOI 10.3389/frai.2025.1692829.s001(source: https://frontiersin.figshare.com/articles/dataset/Data_Sheet_1_Comparative_diagnostic_accuracy_of_artificial_intelligence-derived_risk_stratification_versus_conventional_risk_stratification_methods_in_pulmonary_hypertension_patients_a_systematic_review_and_meta-analysis_docx/30656270)。
数据缺失?
依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。
⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。




